End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
56.52 CNY | +2.60% |
|
+4.13% | +7.97% |
Jul. 08 | Amoytop Biotech Gets China Nod to Test Thrombocythemia Drug | MT |
Apr. 22 | Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.97% | 3.17B | |
+6.96% | 101B | |
+8.29% | 42.63B | |
-11.09% | 33.5B | |
+82.32% | 29.77B | |
-11.82% | 16.14B | |
+1.39% | 14.31B | |
-12.13% | 11.55B | |
+176.65% | 10.53B | |
+6.74% | 9.2B |
- Stock Market
- Equities
- 688278 Stock
- News Xiamen Amoytop Biotech Co., Ltd.
- Amoytop Biotech Signs Exclusive Commercialization Deal With Fosun Unit